Mullins Kevin Michael
Known title: Chief Development OfficerCIK: 0001864233
Associated companies
Transaction History
| LFST | ▼ Sell | Open Market | 85,093 | $471K | 6/11/2024 | View on chart |
| LFST | ▼ Sell | Open Market | 9,688 | $57K | 4/1/2024 | View on chart |
| LFST | ▼ Sell | Open Market | 44,540 | $282K | 3/14/2024 | View on chart |
| LFST | ▲ Buy | Grant | 89,586 | $0 | 3/8/2024 | View on chart |
| LFST | ▲ Buy | Grant | 124,826 | $0 | 3/8/2024 | View on chart |
| LFST | ▼ Sell | Open Market | 115,136 | $923K | 3/1/2024 | View on chart |
| LFST | ▼ Sell | Open Market | 113,334 | $741K | 12/1/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 32,056 | $196K | 11/7/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 300 | $2K | 11/6/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 80,977 | $496K | 11/3/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 113,333 | $749K | 10/2/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 135,400 | $1.2M | 7/6/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 150,000 | $1.3M | 7/5/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 54,600 | $491K | 7/3/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 65,832 | $594K | 6/23/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 69,734 | $531K | 4/4/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 6,399 | $49K | 4/4/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 97,266 | $723K | 4/3/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 43,705 | $268K | 3/16/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 200 | $1K | 3/15/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 800 | $5K | 3/14/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 122,295 | $748K | 3/8/2023 | View on chart |
| LFST | ▲ Buy | Grant | 192,307 | $0 | 3/6/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 82,520 | $580K | 9/30/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 78,858 | $418K | 6/13/2022 | View on chart |
| LFST | ▲ Buy | Grant | 76,446 | $0 | 4/25/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 46,283 | $494K | 4/20/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Keybanc Raises LifeStance Health Price Target to $15
Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.
Keybanc Raises LifeStance Health Price Target to $15. Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.